Last Week’s Top 3 Most Read Posts on Pulmonary Hypertension

Written by Marta Ribeiro |

ph top 3

Read the articles here:

1. PAH Drug Associated with Fewer Deaths, Disease Complications in Phase 3 Study

2. New PAH Drug from Actelion Approved by FDA

3. Reata PH Study Expands to Include Patients with Interstitial Lung Disease